-
Innovation Ranking
NewInnovation Ranking – Aselsan Elektronik Sanayi Ve Ticaret AS
Aselsan Elektronik Sanayi ve Ticaret AS (ASELSAN), part of the Turkish Armed Forces Foundation, manufactures electronic systems for military and commercial applications. The company’s system offerings include military communication systems, space technologies, information technology systems, avionics and navigation systems, naval systems, air, and missile defense systems, security systems, and land and weapon systems. It focuses on research & development, production, testing, engineering, assembling, integration and sales, after-sales support, consultancy, trading activities; and project preparation, engineering, consultancy, training, contracting, regarding various...
-
Innovation Ranking
NewInnovation Ranking – Turkiye Sise ve Cam Fabrikalari AS
Turkiye Sise ve Cam Fabrikalari AS (Sisecam), a subsidiary of Turkiye IS Bankasi AS involves in production and sale of glass and chemicals. The company offers flat glass, coated glass, mirror glass, patterned glass, laminated glass, solar power glass, automotive and encapsulated glass. It also provides chemical products such as soda and chromium chemicals, industrial raw materials, glass fiber, vitamin K3 and sodium metabisulfite. Sisecam produces designed glassware and glass packaging for various industries including pharmaceuticals, food, beverages and cosmetics....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-303 in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Liver Cirrhosis Drug Details: VE-303 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-303 in Hepatic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Hepatic Encephalopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Hepatic Encephalopathy Drug Details: VE-303 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VES-001 in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VES-001 in Frontotemporal Dementia (FTD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VES-001 in Frontotemporal Dementia (FTD) Drug Details: VES-001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-303 in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Clostridioides difficile Infections (Clostridium difficile Associated Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Clostridioides difficile Infections (Clostridium...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-800 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-800 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-800 in Solid Tumor Drug Details: VE-800 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-800 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-800 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-800 in Gastric Cancer Drug Details: VE-800 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-800 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-800 in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-800 in Metastatic Melanoma Drug Details: VE-800 is under development for...
-
Product Insights
Ban Ve
Ban Ve is a Hydro project located in Nghe An, Vietnam. The project is owned by Vietnam Electricity. The project came online in 2010. Empower your strategies with our Ban Ve report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on...